BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17312995)

  • 1. Various tolerances to arsenic trioxide between human cortical neurons and leukemic cells.
    Zhou J; Meng R; Sui X; Li W; Yang B
    Sci China C Life Sci; 2006 Dec; 49(6):567-72. PubMed ID: 17312995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of protein tyrosine kinase, protein tyrosine phosphatase and protein kinase C on the apoptosis of arsenic trioxide treated NB4 cells and human cortex neurons].
    Zhou J; Meng R; Sui XH; Lu M; Wang DS; Yang BF
    Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):600-4. PubMed ID: 15634593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
    Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
    Rojewski MT; Baldus C; Knauf W; Thiel E; Schrezenmeier H
    Br J Haematol; 2002 Mar; 116(3):555-63. PubMed ID: 11849211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
    Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
    Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K; Minami Y; Yamamoto K; Akao Y; Kiyoi H; Saito H; Naoe T
    Leukemia; 2000 Oct; 14(10):1743-50. PubMed ID: 11021749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells.
    Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S
    Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
    Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
    Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA-50/90), a member of the CEA family.
    Di Noto R; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Copia C; Annunziata M; Cimino R; Ferrara F; Del Vecchio L
    Tissue Antigens; 1999 Dec; 54(6):597-602. PubMed ID: 10674975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study on the arsenic trioxide-induced NB4 cell apoptosis and its molecular mechanisms].
    Chen G; Zhu J; Shi X; Zhong H; Liu W; Jin X; Tang W; Li X; Ni J; Xiong S; Shen Z; Ma J; Zhang P; Zhang T; Claude G; Chen S; Chen L; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):25-8. PubMed ID: 15622746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
    Chen Z; Chen GQ; Shen ZX; Chen SJ; Wang ZY
    Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
    Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
    J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
    Alemany M; Levin J
    Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
    Benbijja M; Mellouk A; Bobé P
    Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Dai J; Weinberg RS; Waxman S; Jing Y
    Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.